Updated Intel: US Infant Formula Shortage + Zantac Litigation
Eyes On the latest Intel on Zantac Litigation and the FDA investigation into the US Baby Formula Shortage
Home »
Robin Bateman
Novo Nordisk Acquires Forma Therapeutics
This week we had Eyes On the acquisition of Forma Therapeutics by Novo Nordisk – a typically reticent player in the M&A arena.
Heartburn from Zantac
This week the PharmaTell Team had Eyes On Zantac Litigation Causing Heartburn for Legacy Companies
Amazon + One Medical
This week the PharmaTell Team had Eyes On Pharma Tech Outlook …
PharmaTell Is In the Top 10!
This week the PharmaTell Team had Eyes On Pharma Tech Outlook …
Pharma CI Europe Conference + US FDA Updates + Clinical Data Readouts
We’ve had a busy couple of weeks with the Pharma CI Europe Conference and month end updates. Take a look at what the PharmaTell Team had Eyes on this week.
ASCO + Good News for PPD Patients
As with most of you I’m sure – this week the PharmaTell Team had Eyes on ASCO + positive data for postpartum depression patients.
US Baby Formula Shortage – A Complicated Story
The PharmaTell team had Eyes on the US Baby Formula Shortage. There’s more than meets the eye to the story.
Product Approvals, Delays, & Disappointments
The PharmaTell team had Eyes on new products this week – watching Lilly’s Mounjaro approval, UBS’s Bimzelx CRL, and Roche’s SKYSCRAPER-1 data.
Quarterly Results, Biogen, & Conference Planning
The PharmaTell Team has been busy this week curating Quarterly Results Reports & upcoming conference planners + keeping up with Biogen next steps.